X-150769049-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031462.4(CD99L2):āc.774A>Cā(p.Glu258Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000346 in 1,155,186 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031462.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD99L2 | NM_031462.4 | c.774A>C | p.Glu258Asp | missense_variant | 11/11 | ENST00000370377.8 | NP_113650.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD99L2 | ENST00000370377.8 | c.774A>C | p.Glu258Asp | missense_variant | 11/11 | 1 | NM_031462.4 | ENSP00000359403.3 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112635Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34793
GnomAD3 exomes AF: 0.0000156 AC: 2AN: 128528Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 42860
GnomAD4 exome AF: 0.00000192 AC: 2AN: 1042551Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 340003
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112635Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34793
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.804A>C (p.E268D) alteration is located in exon 12 (coding exon 12) of the CD99L2 gene. This alteration results from a A to C substitution at nucleotide position 804, causing the glutamic acid (E) at amino acid position 268 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at